Clinical and molecular genetic features of ARC syndrome
- 1.1k Downloads
Arthrogryposis, renal dysfunction and cholestasis (ARC) syndrome (MIM 208085) is an autosomal recessive multisystem disorder that may be associated with germline VPS33B mutations. VPS33B is involved in regulation of vesicular membrane fusion by interacting with SNARE proteins, and evidence of abnormal polarised membrane protein trafficking has been reported in ARC patients. We characterised clinical and molecular features of ARC syndrome in order to identify potential genotype-phenotype correlations. The clinical phenotype of 62 ARC syndrome patients was analysed. In addition to classical features described previously, all patients had severe failure to thrive, which was not adequately explained by the degree of liver disease and 10% had structural cardiac defects. Almost half of the patients who underwent diagnostic organ biopsy (7/16) developed life-threatening haemorrhage. We found that most patients (9/11) who suffered severe haemorrhage (7 post biopsy and 4 spontaneous) had normal platelet count and morphology. Germline VPS33B mutations were detected in 28/35 families (48/62 individuals) with ARC syndrome. Several mutations were restricted to specific ethnic groups. Thus p.Arg438X mutation was common in the UK Pakistani families and haplotyping was consistent with a founder mutation with the most recent common ancestor 900–1,000 years ago. Heterozygosity was found in the VPS33B locus in some cases of ARC providing the first evidence of a possible second ARC syndrome gene. In conclusion we state that molecular diagnosis is possible for most children in whom ARC syndrome is suspected and VPS33B mutation analysis should replace organ biopsy as a first line diagnostic test for ARC syndrome.
KeywordsLamellar Body Recent Common Ancestor Renal Tubular Acidosis Nephrogenic Diabetes Insipidus Oligohydramnios
The authors would like to thank all the families for their support for this research. This work has been supported by WellChild and CLIMB children’s charities. PG is a GSK Clinician Scientist Fellow. We are grateful to Dr Caillaux for collecting patient information.
- Elias PM, Feingold KR, Fluhr JW (2003). Skin as an organ of protection. In: Freedberg IM, Eisen AZ, Wolff K, et al. (eds) Dermatology in general medicine, 6th edn. McGraw-Hill, New YorkGoogle Scholar
- Gissen P, Johnson CA, Morgan NV, Stapelbroek JM, Forshew T, Cooper WN, McKiernan PJ, Klomp LWJ, Morris AAM, Wraith JE, McClean P, Lynch SA, Thompson RJ, Lo B, Quarrell OW, DiRocco M, Trembath RC, Mandel H, Wali S, Karet FE, Knisely AS, Houwen RHJ, Kelly DA, Maher ER (2004) Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis –renal dysfunction–cholestasis (ARC) syndrome. Nat Genet 36:400–404PubMedCrossRefGoogle Scholar
- Matthews RP, Plumb-Rudewiez N, Lorent K, Gissen P, Johnson CA, Lemaigre F, Pack M (2005) Zebrafish vps33b, an ortholog of the gene responsible for human arthrogryposis-renal dysfunction-cholestasis syndrome, regulates biliary development downstream of the onecut transcription factor hnf-6. Development 132:5295–306PubMedCrossRefGoogle Scholar
- Sanseverino MT, de Souza CFM, Gissen P, Sordi AO, Gus R, Magalhães JA, Schüler-Faccini L (2006) Increased Nuchal translucency in ARC (arthrogryposis, renal dysfunction and cholestasis) syndrome and a discovery of a Portuguese specific mutation in the VPS33B gene. Ultrasound Obstet Gynecol (in press)Google Scholar
- Sprecher E, Ishida-Yamamoto A, Mizrahi-Koren M, Rapaport D, Goldsher D, Indelman M, Topaz O, Chefetz I, Keren H, O’brien TJ, Bercovich D, Shalev S, Geiger D, Bergman R, Horowitz M, Mandel H (2005) A mutation in SNAP29, coding for a SNARE protein involved in intracellular trafficking, causes a novel neurocutaneous syndrome characterized by cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma. Am J Hum Genet 77:242–251PubMedCrossRefGoogle Scholar
- Wolpert S (2000) A new history of India. Oxford University Press, New YorkGoogle Scholar